19-11023541-C-T
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS1
The NM_001387283.1(SMARCA4):c.2883C>T(p.Thr961Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,460,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001387283.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCA4 | NM_001387283.1 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 20 of 36 | ENST00000646693.2 | NP_001374212.1 | |
| SMARCA4 | NM_003072.5 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 20 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 20 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 20 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 20 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 21 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 20 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 20 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.2883C>T | p.Thr961Thr | synonymous_variant | Exon 21 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.2295C>T | p.Thr765Thr | synonymous_variant | Exon 17 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.1527C>T | p.Thr509Thr | synonymous_variant | Exon 13 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.1608C>T | p.Thr536Thr | synonymous_variant | Exon 13 of 27 | ENSP00000493615.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.1368C>T | p.Thr456Thr | synonymous_variant | Exon 12 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.1236C>T | p.Thr412Thr | synonymous_variant | Exon 11 of 25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000681 AC: 17AN: 249792 AF XY: 0.0000666 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460232Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 726394 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Benign:2
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
Rhabdoid tumor predisposition syndrome 2 Benign:1
- -
not provided Benign:1
- -
SMARCA4-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at